Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Changes in commercial leadership at ImClone

This article was originally published in Scrip

Executive Summary

Michael Bailey has resigned his position as senior vice-president of commercial operations at ImClone Systems(US), effective August 1st; he has accepted a senior level commercial position at Synta Pharmaceuticals. ImClone has also appointed Joseph DePinto vice-president of commercial operations, who will assume responsibility for the company's commercial operations department upon Mr Bailey's departure. Mr DePinto has nearly 20 years' experience in pharmaceutical sales, marketing and commercial business strategy for oncology products, and joins from Johnson & Johnson Pharmaceutical Services where he served as global marketing leader of oncology therapeutics since 2006.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts